Overall, the existing literature suggests EZH2’s noncanonical roles to be more evident in cancer where EZH2 frequently shows overexpression due to various genomic alterations, such as genomic loss of EZH2-targeting miRNAs [33,34]. Here, EZH2 is linked to cancer.